Qfitlia Injection, Solution
Product Images NDC 58468-0348

Product Visual Gallery

This gallery contains 33 technical images submitted to the FDA as part of the official labeling for Qfitlia (NDC 58468-0348). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Genzyme Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (6dd2f8ac 6f90 4cbf B197 97d74964135c 01)

Chemical structure diagram of fitusiran, showing its nucleotide sequence with annotations for 2'-deoxy-2'-fluoro and 2'-O-methyl ribonucleotides, phosphorothioate linkages, and a detailed structure illustration of the L96 component.*

FDA Label Image

Image (6dd2f8ac 6f90 4cbf B197 97d74964135c 02)

Instructional diagram showing the Qfitlia (fitusiran) injection, 50 mg/0.5 mL subcutaneous solution. The left side illustrates the device before injection with labeled parts including the blue cap, medicine, plunger stopper, window, and label. The right side shows the device after injection, highlighting the removed blue cap, yellow window indicating injection completion, and an orange needle cover with the needle inside.*

FDA Label Image

Image (6dd2f8ac 6f90 4cbf B197 97d74964135c 03)

An instructional diagram showing contents related to Qfitlia prefilled pen usage, including the prefilled pen, an alcohol wipe, a cotton ball or gauze, and a sharps disposal container, with a note that the alcohol wipe and cotton ball/gauze are not included in the carton.*

FDA Label Image

Image (6dd2f8ac 6f90 4cbf B197 97d74964135c 04)

Qfitlia 50 mg/0.5 mL injection, solution for subcutaneous use. The label shows the brand name Qfitlia and the generic name fitusiran. The product is supplied by Genzyme Corporation. The image features a syringe illustration with the strength and volume clearly indicated on the label.*

FDA Label Image

Image (6dd2f8ac 6f90 4cbf B197 97d74964135c 05)

An instructional diagram showing a close-up of a cartridge or syringe with a yellow solution inside and a red 'X' mark, indicating incorrect handling or placement of the cartridge or syringe.*

FDA Label Image

Image (6dd2f8ac 6f90 4cbf B197 97d74964135c 06)

An instructional diagram illustrating how to check the medicine and dose on a Qfitlia (fitusiran) injection pen. The image highlights the label on the pen displaying the drug name, strength of 50 mg/0.5 mL, and indicates correct verification of the medication before use.*

FDA Label Image

Image (6dd2f8ac 6f90 4cbf B197 97d74964135c 07)

An instructional diagram showing a test cartridge with a label marking indicating where to check the expiration date and lot number. The highlighted inset shows a close-up of the label area with example text placeholders for the lot number and expiration date in the format YYYY-MM.*

FDA Label Image

Image (6dd2f8ac 6f90 4cbf B197 97d74964135c 08)

An illustration highlighting a check window feature on a device, marked with a green checkmark, showing a close-up view of the window on the side of the device.*

FDA Label Image

Image (6dd2f8ac 6f90 4cbf B197 97d74964135c 09)

FDA Label Image

Image (6dd2f8ac 6f90 4cbf B197 97d74964135c 10)

An instructional illustration showing two hands being washed under running water from a faucet, indicating proper hand hygiene or preparation before an injection.*

FDA Label Image

Image (6dd2f8ac 6f90 4cbf B197 97d74964135c 11)

An instructional diagram showing preferred subcutaneous injection sites for Qfitlia (fitusiran) injection solution. Labeled areas on the upper arms indicate injection by caregiver only, while sites on the abdomen and front thighs are indicated for self-injection or injection by caregiver.*

FDA Label Image

Image (6dd2f8ac 6f90 4cbf B197 97d74964135c 12)

An instructional illustration showing a person's hand applying a small adhesive patch or bandage to the skin, likely at the site of a subcutaneous injection. The image depicts proper placement of the patch on the skin surface near the waist or abdomen area.*

FDA Label Image

Image (6dd2f8ac 6f90 4cbf B197 97d74964135c 13)

An instructional illustration showing how to remove the blue cap straight off a Qfitlia prefilled injection device. The diagram highlights the needle inside and includes a caution symbol indicating an action not to perform. The Qfitlia brand name is visible on the injection device.*

FDA Label Image

Image (6dd2f8ac 6f90 4cbf B197 97d74964135c 14)

An instructional illustration showing a hand holding a Qfitlia injection pen at a 90-degree angle to the injection site. The image highlights a window on the injection pen to check during use.*

FDA Label Image

Image (6dd2f8ac 6f90 4cbf B197 97d74964135c 15)

An instructional illustration showing the correct and incorrect technique for administering a subcutaneous injection with a device. The image emphasizes pressing down until the first click is heard, indicating proper needle insertion. It highlights correct needle depth with a green check mark and incorrect depth with a red X.*

FDA Label Image

Image (6dd2f8ac 6f90 4cbf B197 97d74964135c 16)

Illustration showing a hand holding a Qfitlia injection pen with a visible watch window on the device, indicating where to observe the injection progress. The pen is positioned for subcutaneous injection on the skin.*

FDA Label Image

Image (6dd2f8ac 6f90 4cbf B197 97d74964135c 17)

An instructional illustration showing a hand gripping a syringe-like device labeled Qfitlia (fitusiran) for subcutaneous injection. The image highlights a "Window fully yellow" indicator and a prompt for the "2nd CLICK," suggesting a step in the device activation or usage process.*

FDA Label Image

Image (6dd2f8ac 6f90 4cbf B197 97d74964135c 18)

An instructional illustration showing a hand holding a Qfitlia injection pen with the orange cap being removed by pulling upward, indicated by an orange arrow. This image demonstrates how to prepare the subcutaneous injection device for use.*

FDA Label Image

Image (6dd2f8ac 6f90 4cbf B197 97d74964135c 19)

An instructional illustration showing a hand holding a prefilled pen with a blue cap labeled Qfitlia. The pen is being placed into or taken out of a holder or case, demonstrating part of the preparation or storage process for subcutaneous injection.*

FDA Label Image

Image (6dd2f8ac 6f90 4cbf B197 97d74964135c 20)

Illustration showing the components not included in the Qfitlia 20 mg/0.2 mL vial carton. These are a 1 mL syringe with plunger rod and body, a 27-gauge, 0.5-inch injection needle, a sharps container, two alcohol wipes, and a cotton ball or gauze. The note specifies the syringe and needle should have Luer Lock connections.*

FDA Label Image

Image (6dd2f8ac 6f90 4cbf B197 97d74964135c 21)

An illustration showing a vial of Qfitlia injection solution. The vial has a blue cap and contains 20 mg/.2mL or 50 mg/.5mL of fitusiran for subcutaneous use. Insets highlight the label displaying the product name Qfitlia and an expiration date in the format EXP: YYYY-MM.*

FDA Label Image

Image (6dd2f8ac 6f90 4cbf B197 97d74964135c 22)

An instructional illustration showing a gloved hand holding a small vial and another gloved hand holding a capped syringe, demonstrating preparation steps for a subcutaneous injection.*

FDA Label Image

Image (6dd2f8ac 6f90 4cbf B197 97d74964135c 23)

An instructional illustration showing hands removing the flip-off cap from a vial, demonstrating preparation steps for the Qfitlia (fitusiran) injection solution. The image focuses on the vial top being uncovered, indicating how to access the medication prior to use by subcutaneous injection.*

FDA Label Image

Image (6dd2f8ac 6f90 4cbf B197 97d74964135c 24)

An anatomical illustration indicating recommended subcutaneous injection sites for Qfitlia (fitusiran) injection. It highlights the upper arms as injection areas for caregivers only, and the abdomen and front thighs as sites suitable for either self-injection or administration by a caregiver.*

FDA Label Image

Image (6dd2f8ac 6f90 4cbf B197 97d74964135c 25)

An instructional illustration showing a person holding a syringe for subcutaneous injection. One hand grips the syringe barrel while the other hand pulls down on the plunger. The image visually demonstrates the preparation or use of the injection.*

FDA Label Image

Image (6dd2f8ac 6f90 4cbf B197 97d74964135c 26)

An instructional illustration showing a hand holding a syringe filled with a solution. A close-up inset highlights the fingers positioning around the syringe cap or stopper, suggesting a preparation or injection step for a subcutaneous injection.*

FDA Label Image

Image (6dd2f8ac 6f90 4cbf B197 97d74964135c 27)

An instructional illustration showing a hand holding a syringe with a vial on top. A detail highlights the syringe measurement at 0.1 mL, corresponding to a 10 mg dose, with an arrow indicating the plunger being pulled back. The image demonstrates how to measure and draw a 10 mg dose of a medication, likely Qfitlia (fitusiran) injection.*

FDA Label Image

Image (6dd2f8ac 6f90 4cbf B197 97d74964135c 28)

An instructional diagram showing a hand holding a syringe with a plunger being pulled up. An inset highlights the syringe's measurement markings, focusing on a 0.2 mL volume for a 20 mg dose. The illustration demonstrates drawing the correct volume of liquid medication for injection.*

FDA Label Image

Image (6dd2f8ac 6f90 4cbf B197 97d74964135c 29)

An instructional illustration showing a hand administering a subcutaneous injection at an angle between 45 and 90 degrees into the skin. The image depicts proper needle insertion technique using a syringe.*

FDA Label Image

Image (6dd2f8ac 6f90 4cbf B197 97d74964135c 30)

An instructional illustration showing a person administering a subcutaneous injection. One hand holds the syringe, and the other hand prepares the injection site on the skin. An arrow points to the syringe plunger, indicating pressing or pushing the syringe during injection.*

FDA Label Image

Image (6dd2f8ac 6f90 4cbf B197 97d74964135c 31)

An illustration showing a hand reaching over a sharps disposal container with a vial and a syringe inside, depicting safe disposal of injection materials for subcutaneous use.*

FDA Label Image

Principal Display Panel (0.5 mL Syringe Carton)

Carton label for Qfitlia (fitusiran) injection, 50 mg/0.5 mL, a subcutaneous injection solution. The label indicates a single-dose prefilled pen and is marked for prescription use only. The manufacturer listed is Genzyme Corporation. The label includes storage instructions and a request to dispense the medication guide to each patient.*

FDA Label Image

Principal Display Panel (0.2 mL Vial Carton)

Qfitlia (fitusiran) injection 20 mg/0.2 mL carton label for subcutaneous injection. The packaging highlights the proprietary name Qfitlia and strength 20 mg/0.2 mL, notes it is for subcutaneous use only, and includes storage instructions, manufacturer Genzyme Corporation, and a barcode. The label also advises dispensing the medication guide to patients and discarding unused portions of the single-dose vial.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.